The role of HIV serostatus disclosure in antiretroviral medication adherence

AIDS and Behavior

Volumn 10, Issue 5, 2006, Pages 483-493

  Stirratt, Michael J ^a   Remien, Robert H ^a   Smith, Anna ^a   Copeland, Olivia Q ^a   Dolezal, Curtis ^a   Krieger, Daniel ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Adherence; Antiretroviral; Disclosure; HIV; Social support

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT COMPLIANCE; SELF REPORT; SEROLOGY;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SELF DISCLOSURE; SOCIAL SUPPORT;

EID: 33747836858     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-006-9106-6     Document Type: Article

References (58)

1. Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndrome, 31, S123-S127.
2. Bangsberg, D. R., Hecht, F. M., Charlebois, E., Zolopa, A. R., Holodiny, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
3. Bangsberg, D. R., Sharon, P., Charlebois, E. D., Clark, R. A., Roberston, M., Zolopa, A. R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181-1183.
4. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173-1182.
5. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the beck depression inventory-II. San Antonio, TX: Psychological Corporation.
6. Black, B. P., & Miles, M. S. (2002). Calculating the risks and benefits of disclosure in African American women who have HIV. Journal of Obstetric and Gynecological Neonatal Nursing, 31, 688-697.
7. Blaney, N. T., Fernandez, I., Ethier, K. A., Wilson, T. E., Walter, E., & Koenig, L. J., for the Perinatal Guidelines Evaluation Project Group. (2004). Psychosocial and behavioral correlates of depression among HIV-infected pregnantwomen. AIDS Patient Care and STDs, 18(7), 405-415.
8. Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., et al. (1998). The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. New England Journal of Medicine, 339(26), 1897-904.
9. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAiliffe, T. L. (2000). Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
10. Chesney, M. A., Chambers, D. B., Taylor, J. M., & Johnson, L. M. (2003). Social support, distress, and well-being in older men living with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 33, S185-S193.
11. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255-266.
12. Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., & Rabkin, J. (1999). Adherence: a necessity for successful HIV combination therapy. AIDS, 12(Supp A), S271-S278.
13. Chesney, M. A., & Smith, A. W. (1999). Critical delays in HIV testing and care. American Behavioral Scientist, 42, 1162-1174.
14. Christensen, A., & Shenk, J. L. (1991). Communication, conflict, and psychological distance in nondistressed, clinic, and divorcing couples. Journal of Consulting and Clinical Psychology, 59, 458-463.
15. Clark, H. J., Lindner, G., Armistead, L., & Austin, B. (2003). Stigma, disclosure, and psychological functioning among HIV-infected and non-infected African-American women. Women and Health, 38(4), 57-71.
16. Clingerman, E. (2004). Physical activity, social support, and health-related quality of life among persons with HIV disease. Journal of Community Health Nursing, 21(3), 179-197.
17. Cohen, C. I., & Sokolovsky, J. (1978). General Social Survey network items. Connections, 8, 119-122.
18. D'Angelo, L. J., Abdalian, S. E., Sarr, M., Hoffman, N., Belzer, M., & the Adolescent Medicine HIV/AIDS Research Network. (2001). Disclosure of serostatus by HIV infected youth: The experience of the REACH study (Reaching for Excellence in Adolescent Care and Health). Journal of Adolescent Health, 29, 72-79.
19. Demas, P., Schoenbaum, E. E., Wills, T. A., Doll, L. S., & Klein, R. S. (1995). Stress, coping, and attitudes toward HIV treatment in injecting drug users: A qualitative study. AIDS Education and Prevention, 7(5), 429-442.
20. DiMatteo, M. R. (2004). Social support and patient adherence to medical treatment: A meta-analysis. Health Psychology, 23, 207-218.
21. Duran, S., Spire, B., Raffi, F., Walter, V., Bouhour, D., Journot, V., et al. (2001). Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2(1), 38-45.
22. El-Bassel, N., Cooper, D. K., Chen, D. R., & Schilling, R. F. (1998). Personal social networks and HIV status among women on methadone. AIDS Care, 10(6), 735-749.
23. Ewart, C. K. (1991). Social action theory for a public health psychology. American Psychologist, 46, 931-946.
24. Gibb, D. M., Goodall, R. L., Giacomet, V., McGee, L., Compagnucci, A., & Lyall, H,, for the Paediatric European Network for Treatment of AIDS Steering Committee (2003). Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatric Infectious Disease Journal, 22, 56-62.
25. Golin, C., Isasi, F., Bontempi, J. B., & Eng, E. (2002). Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina. AIDS Education and Prevention, 14(4), 318-329.
26. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413-418.
27. Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
28. Heckman, T. G., Anderson, E. S., Sikkema, K. J., Kochman, A., Kalichman, S. C., & Anderson, T. (2004). Emotional distress in nonmetropolitan persons living with HIV disease enrolled in a telephone-delivered coping improvement group intervention. Health Psychology, 23, 94-100.
29. Herek, G. M., Capitanio, J. P., & Widaman, K. F. (2002). HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991-1999. American Journal of Public Health, 92(3), 371-377.
30. Hoff, C. C. McKusick, L., Hillard, B., & Coates, T. J. (1992). The impact of HIV antibody status on gay men's partner preferences: A community perspective. AIDS Education and Prevention, 4, 197-204.
31. Horowitz, M., Adler, N., & Kegeles, S. (1988). A scale for measuring the occurrence of positive states of mind: A preliminary report. Psychosomatic Medicine, 50, 477-483.
32. Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77-S90.
33. Kalichman, S. C., DiMarco, M., Austin, J., Luke, W., & DiFonzo, K. (2003). Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. Journal of Behavioral Medicine, 26(4), 315-332.
34. Kelly, J. A., Murphy, D. A., Bahr, G. R., & Kalichman, S. C. (1993). Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry, 150, 1679-1686.
35. Klitzman, R. L., Kirschenbaum, S. B., Dodge, B., Remien, R. H., Ehrhardt, A. A., Johnson, M. O., et al. (2004). Intricacies and interrelationships between HIV disclosure and HAART: A qualitative study. AIDS Care, 16(5), 628-640.
36. Leserman, J., Jackson, E. D., Petitto, J. M., Golden, R. N., Silva, S. G., Perkins, D. O., et al. (1999). Progression to AIDS: The effects of stress, depressive symptoms, and social support. Psychosomatic Medicine, 61, 397-406.
37. Malcolm, S. E., Ng, J. J., Rosen, R. K., & Stone, V. E. (2003). An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care, 15, 251-261.
38. Mellins, C. A., Kang, E., Cheng-Shiun, L., Havens, J. F., & Chesney, M. A. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17(8), 407-416.
39. Mellins, C. A., Brackis-Cott, E., Dolezal, C., & Abrams, E. J. (2004). The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal, 23, 1035-1041.
40. Morse, E. V., Simon, P. M., Coburn, M., Hyslop, N., Greenspan, D., & Balson, P. M. (1991). Determinants of subject compliance within an experimental anti-HIV drug protocol. Social Science & Medicine, 10, 1161-1167.
41. Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndromes, 18(4), 341-348.
42. Murphy, D. A., Steers, W. N., & Dello Stritto, M. E. (2001). Maternal disclosure of mother's HIV serostatus to their young children. Journal of Family Psychology, 15, 441-450.
43. Murri, R., Ammassari, A., Gallicano, K., De Luca, A., Cingolani, A., Jacobson, D., et al. (2000). Patient-reported nonadherence to HAART is related to protease inhibitor levels. Journal of Acquired Immune Deficiency Syndromes, 24, 123-128.
44. Ouette, M., Juretzko, P., Kroidl, A., Sagir, A., Wettstein, M., Siegrist, J., et al. (2002). Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients. AIDS Patient Care and STDs, 16(9), 413-417.
45. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
46. Prado, G., Feaster, D. J., Schwartz, S. J., Pratt, I. A., Smith, L., & Szapocznik, J. (2004). Religious involvement, coping, social support, and psychological distress in HIV-seropositive African American mothers. AIDS and Behavior, 8, 221-235.
47. Pugatch, D., Bennett, L., & Patterson, D. (2002). HIV medication adherence in adolescents: A qualitative study. Journal of HIV/AIDS Prevention and Education for Adolescents and Children, 5(1-2), 9-29.
48. Remien, R. H., Stirratt, M. J., Dolezal, C., Dognin, J. S., Wagner, G. J., Carballo-Dieguez, A., et al. (2005). Couple-focused support to improve HIV medication adherence: A randomized controlled trial. AIDS, 19, 807-814.
49. Safren, S. A., Radomsky, A. S., Otto, M. W., & Salomon, E. (2002). Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics, 43, 478-485.
50. Serovich, J. M. (2001). A test of two HIV disclosure theories. AIDS Education and Prevention, 13, 355-364.
51. Siegel, K., Schrimshaw, E. W., & Raveis, V. H. (2000). Accounts for non-adherence to antiviral combination therapies among older HIV-infected adults. Psychology, Health & Medicine, 5(1), 29-42.
52. Stirratt, M. J. (2005). I have something to tell you: HIV serostatus disclosure strategies and sexual practices. In P. N. Halkitis, C. Gomez, & R. Wolitski (Eds.), HIV + Sex: The psychological and interpersonal dynamics of HIV-seropositive gay and bisexual men's relationships. Washington, DC: American Psychological Association.
53. Swindells, S., Mohr, J., Justis, J. C., Berman, S., Squier, C., Wagener, M. M., et al. (1999). Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. International Journal of STDs and AIDS, 10(6), 383-391.
54. Wills, T. A., & Fegan, M. F. (2001). Social networks and social support. In A. Baum, T. A. Revenson, & J. E. Singer (Eds.), Handbook of health psychology (pp. 209-234). Mahwah, NJ: Lawrence Erlbaum.
55. Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Annals of Internal Medicine, 139, 810-816.
56. Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V., & Montaner, J. S. (2004). The impact of adherence on CD4 cell count responses among HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 35, 261-268.
57. Zea, M. C., Reisen, C. A., Poppen, P. J., Bianchi, F. T., & Echeverry, J. J. (2005). Disclosure of HIV status and psychological well-being among Latino gay and bisexual men. AIDS & Behavior, 9, 15-26.
58. Zierler, S., Cunningham, W. E., Andersen, R., Shapiro, M. F., Bozzette, S. A., Nakazono, T., et al. (2000). Violence victimization after HIV infection in a U.S. probability sample of adult patients in primary care. American Journal of Public Health, 90(2), 208-215.